Holen Sie sich die Stockscreener-App
8.42
6.13%
-0.55
Vorhandelsmarkt:
8.42
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Why institutional investors increase stakes in Novavax Inc. (NVV1) stockWeekly Market Outlook & Entry and Exit Point Strategies - mfd.ru
The Truth About Novavax Inc (NVAX): Comeback Story or Total Bag Fumble? - AD HOC NEWS
Novavax (NVAX) Rises As Market Takes a Dip: Key Facts - Yahoo Finance Singapore
Human Vaccine Adjuvants Market Forecast with Size and Share Analysis 2026 to 2035 - Insightace Analytic
Novavax, Inc. (NVAX) Investor Outlook: Exploring a Potential 48.15% Upside in the Biotechnology Arena - DirectorsTalk Interviews
Allianz Asset Management GmbH Acquires 872,987 Shares of Novavax, Inc. $NVAX - MarketBeat
(NVAX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
RSI Check: Is Novavax Inc a defensive stockMarket Rally & Reliable Price Breakout Signals - baoquankhu1.vn
Market Review: Is Novavax Inc a defensive stockProduct Launch & Verified Momentum Stock Watchlist - baoquankhu1.vn
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Novavax rises after a seven-day slide - MSN
Novavax, Inc. (NVAX) Stock Analysis: Assessing a 48% Potential Upside Amidst Market Challenges - DirectorsTalk Interviews
Why Novavax (NVAX) Dipped More Than Broader Market Today - Yahoo Finance
Pfizer Taps Novavax Matrix-M To Refresh Vaccine Growth Story - Yahoo Finance
Pfizer Reshapes Portfolio With Metsera Deal Novavax Pact And R&D Push - simplywall.st
Pfizer Q4 Earnings Preview: Analysts Expect Decline - Intellectia AI
Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
Earnings Update: Can Novavax Inc stock outperform in a bear marketJuly 2025 Sector Moves & Free Reliable Trade Execution Plans - baoquankhu1.vn
Novavax COVID-19 vaccine approved by the FDA - MSN
Weekly Earnings: Is Novavax Inc a turnaround storyGap Down & Accurate Technical Buy Alerts - baoquankhu1.vn
AI Stocks: Whats the beta of Novavax Inc stockPortfolio Value Summary & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
BofA Notes Positive Interest in Novavax, Inc. (NVAX) Technology Despite Timing Concerns for Licensed Assets - Finviz
Novavax (NASDAQ:NVAX) Lowered to Sell Rating by Wall Street Zen - MarketBeat
9 High Growth Small Cap Stocks That Are Profitable - Insider Monkey
Moderna Vs. Novavax: 2 Pandemic Vaccine PioneersWhich Offers Better Value Today? (MRNA) - Seeking Alpha
Pfizer Balances Vaccine Expansion And Drug Discounts With Novavax And TrumpRx - Yahoo Finance
This Beaten-Down Biotech Is Showing Signs of Life. Is It a Buy? - Finviz
This Beaten-Down Biotech Is Showing Signs of Life. Is It a Buy? - The Motley Fool
Pfizer Inks $530M Deal for Novavax Matrix-M Adjuvant Technology to Boost Vaccine Pipeline - Finviz
Here's Why Novavax (NVAX) Fell More Than Broader Market - Yahoo Finance
Why Is Pfizer Stock Rising Tuesday? - Sahm
Has Novavax cracked the code for survival in the vaccine arena? - PharmaVoice
Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of "Hold" by Analysts - MarketBeat
Pfizer Reshapes Pipeline With Novavax Deal And ViiV Exit - simplywall.st
Responsive Playbooks and the NVAX Inflection - Stock Traders Daily
Novavax rises after licensing deal with Pfizer - MSN
Novavax, Inc. (NVAX) Stock Analysis: Exploring a 33.84% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - sharewise.com
What's Driving the Market Sentiment Around Novavax Inc? - Benzinga
MRNA vs NVAX: Which vaccine stock is Wall Street more bullish on right now? - MSN
Novavax (NASDAQ:NVAX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Assessing Novavax (NVAX) Valuation After Pfizer Licensing Deal For Matrix M Adjuvant - Sahm
Decliners Report: Is Novavax Inc a play on infrastructure spendingRate Hike & Safe Entry Momentum Tips - baoquankhu1.vn
Will Licensing Novavax’s Matrix-M Adjuvant Reshape Pfizer’s (PFE) Vaccine Platform Strategy? - Yahoo Finance
Reassessing Novavax (NVAX) After Recent Share Price Rebound And Valuation Signals - Yahoo Finance
Novavax grants license for use of Matrix-M adjuvant to Pfizer - MSN
Novavax (NVAX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Novavax Pfizer Licensing Deal Puts Matrix M And Valuation In Focus - Sahm
Key facts: Novavax signs $30M deal with Pfizer; shares rise 19.7% - TradingView — Track All Markets
Novavax, Inc.'s (NASDAQ:NVAX) Price Is Right But Growth Is Lacking After Shares Rocket 46% - 富途牛牛
Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality - marketscreener.com
NVAX Stock Rises Pre-Market As Pfizer Licenses Its Vaccine Technology - Stocktwits
Analysts Favor Novavax Over Moderna After $30M Pfizer Licensing Deal - Intellectia AI
The Bull Case For Pfizer (PFE) Could Change Following Novavax Matrix-M Adjuvant Licensing DealLearn Why - simplywall.st
MRNA Vs NVAX: Which Vaccine Stock Is Wall Street More Bullish On Right Now? - Stocktwits
1.24%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):